Continuous Measurement of Activity in Patients with Muscle Pathology and in Control Subjects

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

ActiSLA is a monocentric academic study. Patients with amyotrophic lateral sclerosis may be included on a voluntary basis. The investigators plan to include a group of approximately 20 patients with ALS. The investigators have planned to assess patient every three months for a year. On each visit, participants will undergo a clinical examination with MRC sum score and Ashworth scores. They will perform few tests ( 6-minutes walk test (6MWT), dynamometric measure, electromyography, Edinburgh Cognitive and Behavioural ALS Screen ) and will answer to some questionaires (dysphagia handicap scale, ALS-SFR-r). After each visit, participants will wear Actimyo for one month daily.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Clinically defined or probable diagnosis of ALS according to El Escorial criteria revised with Awaji's electro-diagnostic algorithm.

• Over 18 years old.

• Signed informed consent

• If patient on Riluzole, the dosage should be stable for 1 month and continued throughout the study period.

Locations
Other Locations
Belgium
CHR Citadelle
RECRUITING
Liège
Contact Information
Primary
Laurie MEDARD
Laurie.Medard@citadelle.be
43218222
Time Frame
Start Date: 2020-09-25
Estimated Completion Date: 2025-05
Participants
Target number of participants: 45
Treatments
Experimental: Patient with ALS
Patient with amyotrophic lateral sclerosis
Sponsors
Leads: Centre Hospitalier Universitaire de Liege
Collaborators: SYSNAV, Centre Hospitalier Régional de la Citadelle

This content was sourced from clinicaltrials.gov